Hair no longer serves such a vital physiological function in humans, but hair loss is still difficult to accept and the psychological impact associated with this can be immeasurable for the individual. Details of several clinical trials of finasteride [Merck & Co.], a potential new systemic agent for the treatment of androgenetic alopecia, were presented at the 19th World Congress of Dermatology [Sydney, Australia; June 1997].